Ezose, Hirosaki University Partner on Glycomics Research Targeting Prostate Cancer | GenomeWeb

By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – Ezose Sciences and Hirosaki University in Japan today announced a glycomics research collaboration to identify new biomarkers for the prediction and monitoring of progress of prostate cancer and other urological cancers.

Under the terms of the deal, Hirosaki researchers will collect urine samples from well-characterized patients and control populations in Japan, and Ezose will analyze the samples using its GlycanMap platform.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

The White House has created a list of cuts, including to the NIH, that could be in a budget bill for this year.

The US National Institutes of Health is to allow applicants to cite preprints just as they would any other research paper, ScienceInsider reports.

Two manuscript pages handwritten by Charles Darwin are going on the auction block, according to the Los Angeles Times.

In PNAS this week: tool to track transcriptome-wide binding, evidence of balancing selection on behavior-linked genes, and more.